Global Ubiquitin Enzymes Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Ubiquitin Enzymes Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 E1 and E2 Enzymes as Therapeutic Targets
  • 1.4.3 E3 Enzymes as Therapeutic Tragets
  • 1.4.4 Dub Enzymes as therapeutic Tragets
  • 1.4.5 Associated Drug Classes
• 1.5 Market by Application
  • 1.5.1 Global Ubiquitin Enzymes Market Share by Application (2014-2025)
  • 1.5.2 Cancer
  • 1.5.3 Biological Engineering
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Ubiquitin Enzymes Market Size
• 2.2 Ubiquitin Enzymes Growth Trends by Regions
  • 2.2.1 Ubiquitin Enzymes Market Size by Regions (2014-2025)
  • 2.2.2 Ubiquitin Enzymes Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Ubiquitin Enzymes Market Size by Manufacturers
  • 3.1.1 Global Ubiquitin Enzymes Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Ubiquitin Enzymes Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Ubiquitin Enzymes Market Concentration Ratio (CR5 and HHI)
• 3.2 Ubiquitin Enzymes Key Players Head office and Area Served
• 3.3 Key Players Ubiquitin Enzymes Product/Solution/Service
• 3.4 Date of Enter into Ubiquitin Enzymes Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Ubiquitin Enzymes Market Size by Type (2014-2019)
• 4.2 Global Ubiquitin Enzymes Market Size by Application (2014-2019)

5 United States

• 5.1 United States Ubiquitin Enzymes Market Size (2014-2019)
• 5.2 Ubiquitin Enzymes Key Players in United States
• 5.3 United States Ubiquitin Enzymes Market Size by Type
• 5.4 United States Ubiquitin Enzymes Market Size by Application

6 Europe

• 6.1 Europe Ubiquitin Enzymes Market Size (2014-2019)
• 6.2 Ubiquitin Enzymes Key Players in Europe
• 6.3 Europe Ubiquitin Enzymes Market Size by Type
• 6.4 Europe Ubiquitin Enzymes Market Size by Application

7 China

• 7.1 China Ubiquitin Enzymes Market Size (2014-2019)
• 7.2 Ubiquitin Enzymes Key Players in China
• 7.3 China Ubiquitin Enzymes Market Size by Type
• 7.4 China Ubiquitin Enzymes Market Size by Application

8 Japan

• 8.1 Japan Ubiquitin Enzymes Market Size (2014-2019)
• 8.2 Ubiquitin Enzymes Key Players in Japan
• 8.3 Japan Ubiquitin Enzymes Market Size by Type
• 8.4 Japan Ubiquitin Enzymes Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Ubiquitin Enzymes Market Size (2014-2019)
• 9.2 Ubiquitin Enzymes Key Players in Southeast Asia
• 9.3 Southeast Asia Ubiquitin Enzymes Market Size by Type
• 9.4 Southeast Asia Ubiquitin Enzymes Market Size by Application

10 India

• 10.1 India Ubiquitin Enzymes Market Size (2014-2019)
• 10.2 Ubiquitin Enzymes Key Players in India
• 10.3 India Ubiquitin Enzymes Market Size by Type
• 10.4 India Ubiquitin Enzymes Market Size by Application

11 Central & South America

• 11.1 Central & South America Ubiquitin Enzymes Market Size (2014-2019)
• 11.2 Ubiquitin Enzymes Key Players in Central & South America
• 11.3 Central & South America Ubiquitin Enzymes Market Size by Type
• 11.4 Central & South America Ubiquitin Enzymes Market Size by Application

12 International Players Profiles

• 12.1 3SBio
  • 12.1.1 3SBio Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Ubiquitin Enzymes Introduction
  • 12.1.4 3SBio Revenue in Ubiquitin Enzymes Business (2014-2019)
  • 12.1.5 3SBio Recent Development
• 12.2 5AM Ventures
  • 12.2.1 5AM Ventures Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Ubiquitin Enzymes Introduction
  • 12.2.4 5AM Ventures Revenue in Ubiquitin Enzymes Business (2014-2019)
  • 12.2.5 5AM Ventures Recent Development
• 12.3 Abbiotec
  • 12.3.1 Abbiotec Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Ubiquitin Enzymes Introduction
  • 12.3.4 Abbiotec Revenue in Ubiquitin Enzymes Business (2014-2019)
  • 12.3.5 Abbiotec Recent Development
• 12.4 Abcam
  • 12.4.1 Abcam Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Ubiquitin Enzymes Introduction
  • 12.4.4 Abcam Revenue in Ubiquitin Enzymes Business (2014-2019)
  • 12.4.5 Abcam Recent Development
• 12.5 AcelRx Pharmaceuticals
  • 12.5.1 AcelRx Pharmaceuticals Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Ubiquitin Enzymes Introduction
  • 12.5.4 AcelRx Pharmaceuticals Revenue in Ubiquitin Enzymes Business (2014-2019)
  • 12.5.5 AcelRx Pharmaceuticals Recent Development
• 12.6 Aegera Therapeutics
  • 12.6.1 Aegera Therapeutics Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Ubiquitin Enzymes Introduction
  • 12.6.4 Aegera Therapeutics Revenue in Ubiquitin Enzymes Business (2014-2019)
  • 12.6.5 Aegera Therapeutics Recent Development
• 12.7 Aeneas Ventures
  • 12.7.1 Aeneas Ventures Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Ubiquitin Enzymes Introduction
  • 12.7.4 Aeneas Ventures Revenue in Ubiquitin Enzymes Business (2014-2019)
  • 12.7.5 Aeneas Ventures Recent Development
• 12.8 Agilis Biotherapeutics
  • 12.8.1 Agilis Biotherapeutics Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Ubiquitin Enzymes Introduction
  • 12.8.4 Agilis Biotherapeutics Revenue in Ubiquitin Enzymes Business (2014-2019)
  • 12.8.5 Agilis Biotherapeutics Recent Development
• 12.9 Aileron Therapeutics
  • 12.9.1 Aileron Therapeutics Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Ubiquitin Enzymes Introduction
  • 12.9.4 Aileron Therapeutics Revenue in Ubiquitin Enzymes Business (2014-2019)
  • 12.9.5 Aileron Therapeutics Recent Development
• 12.10 Aju IB Investment
  • 12.10.1 Aju IB Investment Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Ubiquitin Enzymes Introduction
  • 12.10.4 Aju IB Investment Revenue in Ubiquitin Enzymes Business (2014-2019)
  • 12.10.5 Aju IB Investment Recent Development
• 12.11 Alexion Pharmaceuticals
• 12.12 Almac Discovery
• 12.13 Amgen
• 12.14 Angelman Syndrome Foundation
• 12.15 Apeiron Biologics
• 12.16 Boston Biochem
• 12.17 Boston University Technology Development Fund
• 12.18 BostonBiochem
• 12.19 BPS Biosciences
• 12.20 Business Development Bank of Canada
• 12.21 Business Development Corporation (BDC) Capital
• 12.22 C4 Therapeutics
• 12.23 Calculus Capital
• 12.24 Canaan Partners
• 12.25 Cancer Research Technology
• 12.26 Captor Therapeutics
• 12.27 Carmot Therapeutics
• 12.28 Cayman Chemicals
• 12.29 Celgene Corporation
• 12.30 Cell Signaling Technology

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer